Related Experiment Videos
Toward a statistically relevant calibration end point for prostate seed implants
D P Rosenzweig1, M C Schell, Y Yu
1Department of Radiation Oncology, University of Rochester Medical Center, New York 14642, USA. rosenrosen@usa.net
Medical Physics
|February 5, 2000
Summary
Radioactive seed strength variability has minimal impact on prostate brachytherapy dose delivery. Current guidelines on seed variability are likely too strict for prostate seed implants, suggesting a need for reevaluation.
Area of Science:
- Medical Physics
- Oncology
- Radiation Therapy
Background:
- Interstitial brachytherapy for prostate cancer uses radioactive seeds for precise dose delivery.
- Accurate dosimetry relies on both seed placement and consistent seed strength.
- Variability in individual seed strengths can affect the delivered radiation dose.
Purpose of the Study:
- To quantify the dose reduction caused by seed strength variability in prostate brachytherapy.
- To assess the impact of seed strength variability on the minimum peripheral dose (mPD).
- To evaluate the stringency of current AAPM guidelines for prostate seed implantation.
Main Methods:
- Statistical analysis of dose reduction due to seed strength variability.
- Focus on the independence of seed placement and seed strength issues.
- Calculation of mPD reduction under varying seed strength conditions.
Main Results:
- Seed strength variability causes a <0.4% reduction in mPD for average prostate configurations.
- The maximum observed reduction in mPD was <1.5%.
- This reduction is significantly lower than overall accuracy recommendations (e.g., AAPM TG 40).
Conclusions:
- Seed strength variability is a minor concern in prostate brachytherapy.
- Current AAPM guidelines on seed-to-seed variability may be overly stringent for prostate applications.
- Reevaluation of constraints on seed strength variability is warranted.